Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $3,708 | $2,676 | $9,371 | $19,518 |
Gross Profit | 3,708 | 481 | 7,729 | 17,861 |
EBITDA | -51,180 | -61,208 | -37,233 | -30,058 |
EBIT | -52,884 | -63,402 | -38,874 | -31,715 |
Net Income | -51,854 | -50,802 | -39,856 | -26,547 |
Net Change In Cash | 3,708 | 2,676 | 9,371 | 19,518 |
Free Cash Flow | -9,764 | -40,267 | -45,123 | -70,840 |
Cash | 879,520 | 890,862 | 961,363 | 456,997 |
Basic Shares | 69,051 | 68,988 | 51,992 | 42,560 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $35,275 | $26,976 | $14,463 | $11,697 |
Gross Profit | 35,275 | 20,509 | 10,776 | -33,183 |
EBITDA | -164,892 | -183,400 | -112,964 | -64,081 |
EBIT | -172,066 | -189,946 | -116,650 | -65,490 |
Net Income | -169,031 | -180,664 | -112,717 | -66,819 |
Net Change In Cash | 35,275 | 26,976 | 14,463 | 11,697 |
Free Cash Flow | -165,959 | -63,557 | -105,098 | -16,824 |
Cash | 879,520 | 526,423 | 339,154 | 438,680 |
Basic Shares | 582,075 | 35,592 | 29,660 | 25,061 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.81 |
2024-09-30 | -$0.74 |
2024-06-30 | -$0.77 |
2024-03-31 | -$0.62 |
